Leading a New Era of Health Sequences

This installment of The Axis Effect features Navid Alipour, Founder/Co-Founder and CEO at AI Med Global, CureMetrix, and CureMatch. While running his Co-Founded fund Analytics Ventures, Alipour began to learn of various companies that utilize artificial intelligence specializing in medical technology, prompting him to pursue his longtime passion for healthcare and become a leader in three A.I.-based medical technology companies. These advancements include CureMetrix’s using of A.I. to aid radiologists in detecting anomalies found in mammograms and CureMatch helping with cancer detection for all individuals.  Alipour discusses how all of his companies are working to improve the quality of cancer treatment through A.I., how far medical technology can grow in the short term and A.I.’s overall growth in usage in medical fields. To learn more, tune in to “Leading a New Era of Health Sequences.”